To directly assess microvascular damage associated with elevated levels of these proinflammatory DAMPs in AD and MCI patients, we next determined whether HMGB1 and/or the proinflammatory coagulation protease, thrombin, players in vascular barrier dysfunction in other tissues could disrupt BBB integrity. This evidence concerns the gene HMGB1 and Alzheimer disease.